L19TNF Clinical Trials
4 recruitingDrug
Phase 24Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 2
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
Locally Advanced Basal Cell Carcinoma
Philogen S.p.A.180 enrolled3 locationsNCT07227350
Recruiting
Phase 2
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
Glioblastoma
Philogen S.p.A.90 enrolled8 locationsNCT06336291
Recruiting
Phase 2
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients
Melanoma Stage IVMelanoma Stage III
Philogen S.p.A.162 enrolled1 locationNCT06284590
Recruiting
Phase 1Phase 2
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
Glioblastoma
Philogen S.p.A.142 enrolled15 locationsNCT04573192